[Malignant pheochromocytoma]

Nihon Rinsho. 2006 May 28:Suppl 1:739-43.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • 3-Iodobenzylguanidine / therapeutic use
  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / genetics
  • Adrenal Gland Neoplasms* / physiopathology
  • Adrenal Gland Neoplasms* / therapy
  • Adrenalectomy
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers / analysis
  • Catecholamines / analysis
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Diagnosis, Differential
  • Diagnostic Imaging
  • Germ-Line Mutation
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / genetics
  • Pheochromocytoma* / physiopathology
  • Pheochromocytoma* / therapy
  • Prognosis
  • Radiopharmaceuticals / therapeutic use
  • Succinate Dehydrogenase / genetics
  • Vincristine / administration & dosage

Substances

  • Biomarkers
  • Catecholamines
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine
  • Vincristine
  • Dacarbazine
  • Cyclophosphamide
  • Succinate Dehydrogenase

Supplementary concepts

  • CVD protocol